TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse October 11, 2013
TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive Colorado Governor Signs Bill Mandating Reimbursement For Mammography Screening April 21, 1989